Toward modeling metabolic state from single-cell transcriptomics
The tetrahydrochloride form of trientine was approved in 2022 by the Food and Drug Administration (FDA) for previously treated Dpenicillaminetolerant patients with WD

(R)-limonene 6-monooxygenase, (S)-limonene 6-monooxygenase, (S)-limonene 7-monooxygenase, CP2C9_HUMAN, CPC9, CYP2C, CYP2C10, CYPIIC9, Cytochrome P-450MP, Cytochrome P450 2C9, Cytochrome P450 MP-4, Cytochrome P450 MP-8, Cytochrome P450 PB-1, Cytochrome P450, family 2, subfamily C, polypeptide 9, MGC149605, MGC88320, Microsomal monooxygenase, NF-E2-related factor 2, NF2L2_HUMAN, NRF2, Nfe2l2, Nuclear factor, Nuclear factor (erythroid derived 2) like 2, Nuclear factor erythroid 2-related factor 2, Nuclear factor erythroid derived 2 like 2, OTTHUMP00000020135, P450 MP, P450 PB 1, P450IIC9, S-mephenytoin 4-hydroxylase, Xenobiotic monooxygenase, cytochrome P-450 S-mephenytoin 4-hydroxylase, erythroid derived 2, flavoprotein-linked monooxygenase, like 2, nuclear factor erythroid 2 like 2 Chemical Structure Lab Chemical Structure - Ethacrynic acid, Glutathione S-transferase (GST) inhibitor (AB141399) 2D chemical structure image of ab141399, Ethacrynic acid, Glutathione S-transferase (GST) inhibitor Need more advice on solubility, usage and handling

A: Simply drop one tablet into a glass of water and wait until it dissolves completely